Clinical Trials on DNA Methylation

Total 23027 results

University Hospital, Essen

Not yet recruiting

Optimization of Radiation Protection Through Genomic Analyses (ORtogether)

Cancer | Radiation | DNA

Germany
Benha University
Hawaa Fertility Center

Terminated

Effect of Different Sperm Processing Methods in ICSI Outcome.

Sperm DNA Fragmentation

Egypt
Ganin Fertility Center
The Cleveland Clinic; University of the Western Cape

Completed

Sperm Selection by Either PICSI or MACS in Cases With Abnormal Sperm DNA Fragmentation Index for ICSI

Sperm DNA Fragmentation

Egypt
Tufts University
BASF

Completed

Biological Functions of Carotenoids in Humans

Oxidative DNA Damage

United States
Zeynep Kamil Maternity and Pediatric Research and...

Not yet recruiting

Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique

DNA Damage | Granulosa Cells
Affiliated Hospital to Academy of Military Medical...

Recruiting

Multimodal Imaging Based on Pathological and Genomic Characteristics

Endoscopy | Mitochondrial DNA Mutation

China
Avva Rus, JSC
St. Vladimir Moscow Children's Clinical Hospital; Arhangelsk Regional Children...

Unknown

A Pilot Study of Filtrum-STI in Children With Viral Gastroenteritis (F-GE-09)

Viral Gastroenteritis

Russian Federation
Ricard Marcos
Finnish Institute of Occupational Health

Recruiting

Biomonitoring of Occupationally Populations Exposed to Micro and Nanoplastic

Occupational Exposure | Genotoxicity | Damage Dna

Finland, Spain
Northwell Health
Organon

Terminated

Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)

Sperm DNA Impact on ART Outcomes

United States
Laval University

Recruiting

Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children

Hepatitis B

Canada
Hospices Civils de Lyon

Recruiting

Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure. (CirB-RNA)

Hepatitis B

France, Italy
PT Bio Farma

Completed

Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children

Hepatitis B

Indonesia
VBI Vaccines Inc.

Completed

Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®

Hepatitis B

Russian Federation
Institut Pasteur

Withdrawn

Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in Senegal (NeoVac2S)

Hepatitis B
Baylor Research Institute

Completed

Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients

Hepatitis B

United States
Mount Sinai Hospital, Canada
University of Toronto

Withdrawn

Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders

Hepatitis B

Canada
Hasselt University

Unknown

Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg (HBVTR)

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs

Hepatitis B

Belgium, Ukraine, Australia
Maastricht University Medical Center
CyTuVax

Completed

Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders

Hepatitis B

Netherlands
GlaxoSmithKline

Completed

Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination

Hepatitis B

Germany
GlaxoSmithKline

Completed

Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

Hepatitis B | Hepatitis A

Australia, Belgium, Spain
GlaxoSmithKline

Completed

Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine

Hepatitis B

Germany, Belgium
GlaxoSmithKline

Completed

Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination

Hepatitis B | Hepatitis A

Belgium, Czechia
GlaxoSmithKline

Completed

Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults

Hepatitis B | Hepatitis A

Belgium
Merck Sharp & Dohme LLC

Completed

Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)

Hepatitis B
GlaxoSmithKline

Completed

Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children

Hepatitis B

Germany
Merck Sharp & Dohme LLC

Completed

A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)

Hepatitis B
Merck Sharp & Dohme LLC

Completed

Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED)

Hepatitis B
GlaxoSmithKline

Completed

Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.

Hepatitis B

Thailand
GlaxoSmithKline

Completed

LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers

Hepatitis B

Thailand
GlaxoSmithKline

Completed

Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge

Hepatitis B

Germany
Massachusetts General Hospital

Completed

The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults

Hepatitis B

United States
GlaxoSmithKline

Completed

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

Hepatitis B

Belgium
University of Surrey

Completed

A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines

Hepatitis B

United Kingdom
GlaxoSmithKline

Withdrawn

Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)

Hepatitis B | Hepatitis A

Czech Republic
GlaxoSmithKline

Completed

Acceptability of Hepatitis B Vaccination in General Population (PopCorn)

Hepatitis B
Beijing Municipal Science & Technology Commission

Unknown

Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination

Hepatitis B

China
National Taiwan University Hospital
National Science Council, Taiwan

Completed

The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines

Hepatitis B

Taiwan
Henogen
GlaxoSmithKline

Completed

A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.

Hepatitis B

Belgium, Czech Republic, Hungary
Henogen

Completed

Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule

Hepatitis B

Czech Republic
GlaxoSmithKline

Completed

Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B

Hepatitis B

Austria
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine

Hepatitis B

Austria
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y

Hepatitis B

Australia, Czech Republic, Germany, Italy, Netherlands, Switzerland, United Kingdom
GlaxoSmithKline

Completed

Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults

Hepatitis B

Austria, Belgium, Denmark, Iceland
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

Hepatitis B

Belgium
Centers for Disease Control and Prevention
Alaska Native Medical Center

Completed

VaxTeen Hepatitis B Vaccine Booster Study

Hepatitis

United States
St. Joseph's Health Care London

Completed

Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients

Hepatitis B

Canada

3

Subscribe